Health

Oral and Maxillofacial Reconstructive Surgery at The University of Hong Kong, Powered by Large Multimodal Model for Medicine

HONG KONG, July 17, 2024 /PRNewswire/ -- In June 2024, a surgical team led by ProfessorRichard Y. Su and Dr. Jane J. Pu from the Faculty of Dentistry at The University of Hong Kong, in collaboration with United Imaging Intelligence (UII), has achieved a groundbreaking AI-assisted oral and maxillo...

2024-07-18 00:00 1952

Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse

BOSTON, July 17, 2024 /PRNewswire/ -- Immunocan announced the successful construction of new strain of fully human antibody platform: ImmuMab® HKL mouse. This new mouse was created by in-situ replacing the variable region of Immunoglobulin genes of mouse by its counterparts from human. With Lambd...

2024-07-17 21:50 1428

Operation Smile Announces Align Technology as Title Sponsor of International Student Leadership Conference

Announcement reflects Align Technology's continued partnership in Operation Smile's commitment to youth development through education, service, and leadership opportunities VIRGINIA BEACH, Va. and TEMPE, Ariz., July 17, 2024 /PRNewswire/ -- Operation Smile announced today that Align Technology, ...

2024-07-17 21:00 1792

ZAGENO Recognized with Frost & Sullivan's 2024 Global Customer Value Leadership Award for Transforming the Lab Supply Procurement Experience

ZAGENO leverages advanced AI and a robust online platform to optimize lab supply procurement and deliver cost-effective efficiency. SAN ANTONIO, July 17, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the life sciences eCommerce industry and, based on its findings, recognizesZAGENO wi...

2024-07-17 19:00 1506

Bangkok Hospital Hat Yai Achieves GHA Accreditation, Affirming Its Position as a Premier Medical Travel Destination

PALM BEACH GARDENS, Fla., July 17, 2024 /PRNewswire/ -- Bangkok Hospital Hat Yai , a leading healthcare provider in Songkhla Province,Thailand, has recently been awarded the prestigious Accreditation for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This recognition serves as a ...

2024-07-17 18:00 1612

Bangkok Hospital Hat Yai Achieves GHA Accreditation, Affirming Its Position as a Premier Medical Travel Destination

PALM BEACH GARDENS, Fla., July 17, 2024 /PRNewswire/ -- Bangkok Hospital Hat Yai , a leading healthcare provider in Songkhla Province,Thailand, has recently been awarded the prestigious Accreditation for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This recognition serves as a ...

2024-07-17 18:00 1549

First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam

HSINCHU, July 17, 2024 /PRNewswire/ -- Brain Navi announces the completion of its first case inNetherlands, which was successfully and safely performed at Erasmus MC inRotterdam, Netherlands. Brain biopsy helps doctors decide the best treatment for the patient after taking a tissue sample from t...

2024-07-17 15:49 1926

New COSMOS research reveals Centrum Silver supports cognitive health in healthy older adults

The simple act of taking Centrum Silver multivitamin supplements daily can support cognition among those aged 60 years and above  * Experts emphasise the relevance of cognitive decline as a critical age-related health issue inSingapore given its aging population, and spotlight the importance o...

2024-07-17 15:00 1921

111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024

SHANGHAIJuly 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will partic...

2024-07-17 13:31 1423

GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities

* Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis * Including blockbuster drugs such as 'Keytruda' and 'Yervoy', GCCL offers tailored clinical trial analysis services for biosimilar development YONGIN, South Korea...

2024-07-17 10:38 1681

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

* CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at itsColorado, US site and in Europe. The expansions, covering both existing facilities and new constructions, will meet the pharmaceutical industry's most stringent quality and...

2024-07-17 10:16 2424

Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' radiopharmaceutical compound into an innovative anti-cancer treatment for worldwide markets HEIDELBERG, Germany and SEOUL, South Korea, July 16, 2024 /PRNewswire/ ...

2024-07-17 10:00 1360

Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks

CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be jointly hosted by HitGen Inc. and Xtalks onWednesday July 17, 2024, at 2pm EDT ( 11am PDT). Alex Shaginian, PhD, Vice President of Business Deve...

2024-07-16 23:55 2129

ShiraTronics Unveils Data on their Neurostimulation System for Chronic Migraine

MIAMI BEACH, Fla., July 17, 2024 /PRNewswire/ -- ShiraTronics, a trailblazing clinical-stage neurostimulation company, proudly presented findings from its Australian Pilot Study, RELIEV-CM, at the American Society of Pain and Neuroscience (ASPN) Pain Conference. This pioneering study showcases th...

2024-07-16 22:10 2021

FDA Grants Orphan Drug Designation to 7MW3711

SHANGHAI, July 16, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel B7-H3-targeting ADC (R&D code: 7MW3711) has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Adminis...

2024-07-16 22:00 1955

Athletes' health - effects of environmental pollutants and nutrition on epithelial barrier function and healthy microbes in the body

Novel concepts highlight a holistic approach to overall health and physical performance of athletes (professional sporters and physically active persons), linked with their nutrition and exposure to pollution and toxic substances affecting the integrity of their barriers of skin and mucosal body ...

2024-07-16 21:36 1721

Shaping the Future: Forum 30, The MPHO Safety and Traceability Summit in Rome

REDLANDS, Calif., July 16, 2024 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authorities for bloodCentro Nazionale Sangue ("CNS") and cells/tissuesCentro Nazionale Trapianti ("CNT"), will be ho...

2024-07-16 21:00 1489

SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems

WILMINGTON, Del., July 16, 2024 /PRNewswire/ -- SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in princip...

2024-07-16 21:00 1531

IMG Welcomes Susan Yates as Chief Customer Officer

INDIANAPOLIS, July 16, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is pleased to introduceSusan Yates as the company's new Chief Customer Officer. Yates joins the IMG team with more than 25 years of experience...

2024-07-16 21:00 1438

Bloomage Launches MitoPQQ™ and Presents Hyaluronic Acid Research at IFT FIRST Expo 2024

CHICAGO, July 16, 2024 /PRNewswire/ -- Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, launched its new product - MitoPQQ™ and presented its latest hyaluronic acid research at the 2024 IFT FIRST expo, one of the largest gatherings of global exp...

2024-07-16 21:00 1309
1 ... 55565758596061 ... 858